DOCSLIB.ORG

Physician's Newsletter

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Physician's Newsletter PUBLISHED BY AMERICAN MEDICAL SOCIETY PHYSICIAN'S ON ALCOHOLISM, Inc. Two Park Avenue New York, N.Y. 10016 Vol. 5, No.4 Fall, 1970 © Copyright 1970 American Medical Society on Alcoholism, Inc. NEWSLETTER All Rights Reserved ADVANCES IN ALCOHOLISM "Mini-Delusions" Trouble Alcoholics, Browne-Mayers RESEARCH REPORTED AT Tells Eastern Psychiatric Research Meetings . ~atients. suffel'in~ from nlcoh?lism and dtug abuse may experience "mini-delu- LIVER DISEASE MEETINGS SIOns -that 1s, recurnng false behefs that alter behavior and thinking-reported Dr. A. .N . Bro';ne-~ayers ~nd a team .of psychiatrists from The New York Hospital, Research reports on alcoholism and C01nell Umvemtr, ~.edical College 111 .White Plains to the 15th Annual Meeting of alcohol-related factors in liver disease the E~stem Psyc.luatl.lC Research Association. TlJ,e theme of the meeting, which was were presented at the 21st Annual Meet­ held 11.1 . ~w York Ctty on oven:ber 7-8, was Drug Abuse: Current Concepts and ing of the American Association for the ~e~ea10l.1. Dr. Brown~-Mayers smd that even though the patient appears to achieve Study of Liver Diseases held November 1~1S1ght .utto th.e d e l .u~tons, .the err~n~ous belief will frequently reappear at a later 4-5, 1970, in Chicago. Following are tu~e Wlt~l ~II Jts ?n~n~al v1gor .. MmJ-delusions are dependent upon psychodynamic some of the highlights of the meetings. f01ces w1thm the mdlv!dual pat1ent and are also closely allied to denial mechanisms. In a series of about 50 addiction Rates of Ethanol Metabolism Decrease patients, mini-delusions were seen clearly Following Withdrawal from Alcohol NAAAP ANNUAL MEETING at least five times. As an example, Dr. The rates of ethanol disappearance Browne-Mayers cited an alcoholism pa­ from the blood and the activities of the DISCUSSES ALCOHOL tient who complained that she had been ethanol oxidizing enzymes were studied taken off the debutante committee of the in 25 chronic alcoholics during ethanol Junior League in her community. Investi­ ingestion and withdrawal to determine AND ADDICTIONS gation showed that she had never even hether or not changes in the rates were been on such a committee. When she was Addictions in their various forms were .. ccompanied by parallel changes in the given this information, she seemed to discussed by experts in many fields at activity of the enzymes. In the study, accept it as true, but a few weeks later, the 21st Annual Meeting of the North conducted by E. Mezey of the Baltimore and then months later, she returned to American Association of Alcoholism Pro­ City Hospitals and Johns Hopkins Uni­ her original recollection of the upsetting grams held in San Antonio, Texas, Sep­ versity School of Medicine, the patients, time "when they took me off the com­ tember 27-0ctober 2, 1970. who had a history of recent alcohol in­ mittee." take and no overt clinical evidence of In the Clinical Symposium, Daniel X. Freedman, M.D., Professor and Chair­ Mini-delusions characteristically are live•• disease, were placed on a normal generally plausible and not bizarre. The diet supplemented by ethanol for 3-5 man of the Department of Psychiatry of the University of Chicago, discussed the emotion or the accompanying affect is days. A liver biopsy was obtained wlth generally within normal range. They do assay of the two enzyme activities on growing problem of addiction in "The Great Stoned Age." Relating the abuse not occupy the whole spectrum of the liver homogenates. Repent studies were patient's mental life. The conviction dis­ perfo••med on 12 patients after 1, 2, and of alcohol and drugs to the larger prob­ lem of wh~t societ~ defines as accept­ ~ppears completely at times, reappears 3 weeks of continuous hospitalization m other cases, is denied in still others and abstinence from alcohol. Liver bi­ able behav10r, he sru.d that every society that use~ drugs invents customs to regu­ and. is frequent~y rationalized. The pro~ opsies revealed val'ious degrees of fatty fesswnal therapist may not realize he is infiltration in 24 patients and alcoholic late thetr use and purpose. The medical professiop, which in a modem tech­ listening to a mini-delusion because it hepatitis in 1. Follow-up biopsies showed is usually plausible and reasonable. Psy­ decreases in fatty infilh·ntion in all the n.ological society is the only system con. - s1dered. capable of handling drugs must chotherapy, group, individual, and milieu patients. The mean 1·ate of ethanol dis­ therapy have been the chief methods to appearances from the blood decreased thread Jts way carefully through the myr­ iad and changing patterns of alcohol deal with this phenomenon. Psycho­ from 19.7 ± 3.2 (SD) to 14.9 ± 0 ..5 mg/ pharmacological agents, when tried, ap­ 100 m1/hr (p < .001) within one week and drug abuse to determine wby a particular person uses thugs, what it peru· to exert little influence in over­ of discontinuation of ethanol. ADH in­ coming this problem. creased during the 1st and 2nd week means to him, and bow to help him from 9.3 ± 3.2 to 19.0 ± 5.6 micromoles/ learn new behaviors once he is off the Fatalities Due to Alcoholism · mg protein/hr (p < .001), and decreased dru~ Are Under-Reported in New York In addition to the general sessions, back to normal values in the 3rd week. Mic.l1ael M. Baden, M.D., Deputy special panel discussions were also held ~ccording to Mezey, these findings sug- Chief Medical Examiner of the City of for various sections: Administration I}St that the J"ates of ethanol disap­ ew York, reported that deaths due to Community Action, Education, Research earance from the blood are J"egulated nlcohousm are widely under-reported. In and Training, Social Work, and Treat­ by factors other than the absolute activi­ ew Yol'k City last year, of the more ment Services. The host agency for the ties of tbe ethanol oxidizing enzymes. than 6,000 deaths related to alcoholism conference was the Texas Commission ' (Continued on page 5) on Alcoholism. (Continued on page 6) 1 EDITORIAL MEETINGS Exploding A Myth ject does not correspond with the facts JANUARY 25-28, 1971 - 38th Annual About Alcoholism . (The) false belief (that alcoholism Meeting, National Association of Private The study of alcoholism is confused remans an insignificant phenomenon) Psychiatric Hospitals. Sonesta Beac· by many misconceptions-often impres­ has been shared by a number of foreign Hotel, Key Biscayne, Florida. Informa­ sionistic statements from the untested ex­ researchers, such as Sadon, Lolli, and tion from NAPPH, 353 Broad Avenue, perience of one man, copied without in­ Silverman, all of whom have been dis­ Leonia, N.J. 07605. vestigation until they become axioms, so proved by Perrin." ,I encased in authority that to question Tracing the increase of admissions of THURSDAY, JANUARY 28, 1971, 8:30 them is heresy. Though it is difficult alcoholic psychoses to mental hospitals p.m. - AMSA meeting, featuring film enough to gain a hearing for su~h her­ (from 900 in 1947 to 2,700 in 1962) and "Eagleville-You're Not Alone." Discus­ esies when they attack an undocumented their percentage of all mental hospital sants will be Howard D. Zucker, M.D., pronouncement, it is even more counl­ admissions ( 4.4% in 1947 and 12% in and Stua1t E. Nichols, M.D. Hanger geous to call attention to the incorrect­ 1962), and noting that the incidence of Amphitheater, Ninth Floor, College of ness of a myth which has been buttressed cirrhosis of the liver has increased at a Physicians and Surgeons, 630 W. 168th. by "evidence." similar rate, Mastrangelo deplores the For this reason it is refreshing to read effect of the notion that if one is Italian APRIL 27-29, 1971 - NCA National Giuseppe Mastrangelo's essay, "Recent he is not likely to be alcoholic. Meetings, Anaheim, Calif. Infonnation Developments in the Struggle against from NCA, 2 Park Ave., New York City. Alcoholism in Italy.""' Masb·angelo says: Unfortunately the force of Dr. Mas­ "In Italy public opinion as a whole con­ trangelo's argument is blunted by his siders that there can be individual alco­ failure either to quote or give a refer­ International Meetings planned for 1971: holics, but that alcoholism does not exist ence for Perrin's work, as well as by the MAY-Vienna, Austria, Drug Depen­ as a national problem. This same belief very general nature of his statistics. dence; JUNE-West Berlin, Alcoholism; is shared in other parts of the world by However, he has made it clear that alcoholism is indeed a growing problem OCTOBER 5-8-Dublin, Ireland, Alco­ many persons who, in good faith, con­ holism and Drug Dependence. For fur­ sider Italians as an example of sober in Italy, and that we cannot consider ther information, contact Archer Tongue, people, whose general habit of drinking Italians immune from the disease. wine in preference to other spirits does FAS Executive Director, International Coun­ cil on Alcohol and Addictions, Case not lead them to alcoholism. It must now 0 In YForld Dialogue on Alcohol and Drug Dqn:n­ be stated that this belief is without foun­ dence. Elizabeth D. \iVhitney, editor, Beacon Press, postale 140, 1001- Lausanne, Switzer­ dation, and common opinion on the sub- Boston, 1970. land. BOOK REVIEWS The Prevention of Drinking Problems: American Drinking Practices: Proceedings of the Eleventh Annual Alcohol Control and Cultural Influences A National Study of Drinking Behavior Meeting of the American Association and Attitudes for Automotive Medicine By Rupert Wilkinson. New York: Ox­ By Don Cahalan, Ira H.
Load more

Recommended publications
  • NIH Public Access Author Manuscript Pharmacol Ther
    NIH Public Access Author Manuscript Pharmacol Ther. Author manuscript; available in PMC 2010 August 1. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Pharmacol Ther. 2009 August ; 123(2): 239±254. doi:10.1016/j.pharmthera.2009.04.002. Ethnobotany as a Pharmacological Research Tool and Recent Developments in CNS-active Natural Products from Ethnobotanical Sources Will C. McClatcheya,*, Gail B. Mahadyb, Bradley C. Bennettc, Laura Shielsa, and Valentina Savod a Department of Botany, University of Hawaìi at Manoa, Honolulu, HI 96822, U.S.A b Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL 60612, U.S.A c Department of Biological Sciences, Florida International University, Miami, FL 33199, U.S.A d Dipartimento di Biologia dì Roma Trè, Viale Marconi, 446, 00146, Rome, Italy Abstract The science of ethnobotany is reviewed in light of its multidisciplinary contributions to natural product research for the development of pharmaceuticals and pharmacological tools. Some of the issues reviewed involve ethical and cultural perspectives of healthcare and medicinal plants. While these are not usually part of the discussion of pharmacology, cultural concerns potentially provide both challenges and insight for field and laboratory researchers. Plant evolutionary issues are also considered as they relate to development of plant chemistry and accessing this through ethnobotanical methods. The discussion includes presentation of a range of CNS-active medicinal plants that have been recently examined in the field, laboratory and/or clinic. Each of these plants is used to illustrate one or more aspects about the valuable roles of ethnobotany in pharmacological research.
    [Show full text]
  • Quality Use of Medicines in Residential Aged Care
    RESEARCH Quality use of medicines in Michael Somers residential aged care Ella Rose Dasha Simmonds Claire Whitelaw Janine Calver Christopher Beer Background Approximately 190 000 people in high risk of ADEs in frail older people. For example, Older people are more likely to be Australia were estimated to have anticholinergic drugs commonly produce adverse exposed to polypharmacy. People dementia in 2006, with the prevalence effects in elderly people and are more likely to be with dementia, especially those living expected to increase to 465 000 by 2031.1 prescribed to people with dementia than those in residential aged care facilities The prevalence of dementia increases without.7 (RACFs), are at particularly high risk of with age, from 6.5% of Australians aged Antipsychotic medications are commonly used medication harm. We sought to describe medications prescribed for a sample of 65 years and over to 22% of Australians to manage the behavioural and psychological 2 people with dementia living in RACFs. aged 85 years and over. Dementia is symptoms of dementia (BPSD), such as associated with a large burden of disease psychosis, depression, agitation, aggression Methods in Australia’s aging population, costing and disinhibition.1,8 There is concern that A total of 351 residents with dementia Australia $1.4 billion in 2003.2 Most of this antipsychotics are used too frequently as a aged over 65 years were recruited from 36 RACFs in Western Australia. burden was associated with residential first line treatment for BPSD, with the risks of 2 Data on all medications prescribed aged care facilities (RACFs). Dementia antipsychotic use outweighing the benefits at their were collected, including conventional is the medical problem most frequently likely level of use.8 For example, risperidone, an medications, herbal medications, managed by general practitioners atypical antipsychotic prescribed frequently for the vitamins and minerals.
    [Show full text]
  • Health and Social Outcomes Associated with High-Risk Alcohol Use
    Manitoba Centre for Health Policy Health and Social Outcomes Associated with High-Risk Alcohol Use Summer 2018 Nathan C Nickel, MPH, PhD Jeff Valdivia, MNRM, CAPM Deepa Singal, PhD James Bolton, MD Christine Leong, PharmD Susan Burchill, BMus Leonard MacWilliam, MSc, MNRM Geoffrey Konrad, MD Randy Walld, BSc, BComm (Hons) Okechukwu Ekuma, MSc Greg Finlayson, PhD Leanne Rajotte, BComm (Hons) Heather Prior, MSc Josh Nepon, MD Michael Paille, BHSc This report is produced and published by the Manitoba Centre for Health Policy (MCHP). It is also available in PDF format on our website at: http://mchp-appserv.cpe.umanitoba.ca/deliverablesList.html Information concerning this report or any other report produced by MCHP can be obtained by contacting: Manitoba Centre for Health Policy Rady Faculty of Health Sciences Max Rady College of Medicine, University of Manitoba 4th Floor, Room 408 727 McDermot Avenue Winnipeg, Manitoba, Canada R3E 3P5 Email: [email protected] Phone: (204) 789-3819 Fax: (204) 789-3910 How to cite this report: Nathan C Nickel, James Bolton, Leonard MacWilliam, Okechukwu Ekuma, Heather Prior, Jeff Valdivia, Christine Leong, Geoffrey Konrad, Greg Finlayson, Josh Nepon, Deepa Singal, Susan Burchill, Randy Walld, Leanne Rajotte, Michael Paille. Health and Social Outcomes Associated with High-Risk Alcohol Use. Winnipeg, MB. Manitoba Centre for Health Policy, Summer 2018. Legal Deposit: Manitoba Legislative Library National Library of Canada ISBN 978-1-896489-90-2 ©Manitoba Health This report may be reproduced, in whole or in part, provided the source is cited. 1st printing (Summer 2018) This report was prepared at the request of Manitoba Health, Seniors and Active Living (MHSAL), a department within the Government of Manitoba, as part of the contract between the University of Manitoba and MHSAL.
    [Show full text]
  • PHRP March 2015
    March 2015; Vol. 25(2):e2521518 doi: http://dx.doi.org/10.17061/phrp2521518 www.phrp.com.au Research Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: a validation study Danijela Gnjidica,b,i, Sallie-Anne Pearsona,c, Sarah N Hilmerb,d, Jim Basilakise, Andrea L Schaffera, Fiona M Blythb,f,g and Emily Banksg,h, on behalf of the High Risk Prescribing Investigators a Faculty of Pharmacy, University of Sydney, NSW, Australia b Sydney Medical School, University of Sydney, NSW, Australia c Sydney School of Public Health, University of Sydney, NSW, Australia d Royal North Shore Hospital and Kolling Institute of Medical Research, Sydney, NSW, Australia e School of Computing, Engineering and Mathematics, University of Western Sydney, NSW, Australia f Centre for Education and Research on Ageing (CERA), Concord Hospital, Sydney, NSW, Australia g The Sax Institute, Sydney, NSW, Australia h National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT i Corresponding author: [email protected] Article history Abstract Publication date: March 2015 Background: Increasingly, automated methods are being used to code free- Citation: Gnjidic D, Pearson S, Hilmer S, text medication data, but evidence on the validity of these methods is limited. Basilakis J, Schaffer AL, Blyth FM, Banks E. To examine the accuracy of automated coding of previously keyed Manual versus automated coding of free-text Aim: in free-text medication data compared with manual coding of original self-reported medication data in the 45 and Up Study: a validation study. Public Health handwritten free-text responses (the ‘gold standard’).
    [Show full text]
  • Plant Powers, Poisons, and Herb Craft
    PLANT POWERS, POISONS, AND HERB CRAFT BY DALE PENDELL Foreword by Gary Snyde, $21.95 US In 'Pharmako/Poeia, Dale Pendell offers a mesmerizing guide to psychoactive Alternative plants, from their pharmacological roots to the literary offshoots. "This is a Health/ book," writes Gary Snyder, "about danger: dangerous knowledge, even more Literature dangerous ignorance." Against the greater danger, ignorance, Pendell strikes a formidable blow, as he proves himself a wise and witty guide to our plant teach- ers, their powers and their poisons. "Dale Pendell reactivates the ancient connection between the bardic poet and the shaman. His Pharmako/Poeia is a litany to the secret plant allies that have always accompanied us along the alchemical trajectory that leads to a new and yet authentically archaic future." — Terence McKenna, author of True Hallucinations "Much of our life-force calls upon the plant world for support, in medicines and in foods, as both allies and teachers. Pendell provides a beautifully crafted bridge between these two worlds. The magic he shares is that the voices are spoken and heard both ways; we communicate with plants and they with us. This book is a moving and poetic presentation of this dialogue." — Dr. Alexander T. Shulgin, University of California at Berkeley, Department of Public Health "Pharmako/Poeia is an epic poem on plant humours, an abstruse alchemic treatise, an experiential narrative jigsaw puzzle, a hip and learned wild-nature reference text, a comic paean to cosmic consciousness, an ecological handbook, a dried-herb pastiche, a countercultural encyclopedia of ancient fact and lore that cuts through the present 'conservative' war-on-drugs psychobabble." - Allen Ginsberg, poet Cover design "Dale PendelFs remarkable book will make it impossible to and color work ever again underestimate the most unprepossessing plant.
    [Show full text]
  • Development of a Multivariable Prediction Model for Identification of Patients at Risk for Medication Transfer Errors at ICU Discharge
    RESEARCH ARTICLE Development of a multivariable prediction model for identification of patients at risk for medication transfer errors at ICU discharge 1,2 1,3 2,4 Liesbeth B. E. BosmaID *, Nienke van Rein , Nicole G. M. Hunfeld , Ewout W. Steyerberg5, Piet H. G. J. Melief6, Patricia M. L. A. van den Bemt2 1 Haga Teaching Hospital, Department of Clinical Pharmacy, Els Borst-Eilersplein CH, The Hague, The Netherlands, 2 Erasmus University Medical Center, Department of Hospital Pharmacy, CA, Rotterdam, The Netherlands, 3 Leiden University Medical Center, Department of Clinical Pharmacy and Toxicology, Leiden, The Netherlands, 4 Erasmus University Medical Center, Department of Intensive Care, CA, Rotterdam, The a1111111111 Netherlands, 5 Clinical Biostatistics and Medical Decision Making at Erasmus MC, Rotterdam and Leiden a1111111111 University Medical Center, ZA Leiden, The Netherlands, 6 Haga Teaching Hospital, Department of Intensive Care, CH, The Hague, The Netherlands a1111111111 a1111111111 * [email protected] a1111111111 Abstract OPEN ACCESS Introduction Citation: Bosma LBE, van Rein N, Hunfeld NGM, Steyerberg EW, Melief PHGJ, van den Bemt PMLA Discharge from the intensive care unit (ICU) is a high-risk process, leading to numerous (2019) Development of a multivariable prediction potentially harmful medication transfer errors (PH-MTE). PH-MTE could be prevented by model for identification of patients at risk for medication reconciliation by ICU pharmacists, but resources are scarce, which renders the medication transfer errors at ICU discharge. PLoS ONE 14(4): e0215459. https://doi.org/10.1371/ need for predicting which patients are at risk for PH-MTE. The aim of this study was to journal.pone.0215459 develop a prognostic multivariable model in patients discharged from the ICU to predict who Editor: Shane Patman, University of Notre Dame is at increased risk for PH-MTE after ICU discharge, using predictors of PH-MTE that are Australia, AUSTRALIA readily available at the time of ICU discharge.
    [Show full text]
  • Online Appendix
    The More We Die, The More We Sell? A Simple Test of the Home-Market Effect Online Appendix Arnaud Costinot Dave Donaldson MIT, CEPR, and NBER MIT, CEPR, and NBER Margaret Kyle Heidi Williams Mines ParisTech and CEPR MIT and NBER December 28, 2018 1 Contents A Theoretical Appendix3 A.1 Multinational Enterprises (Section III.1)..........................3 A.2 Log-Linearization (Section III.2)...............................3 A.3 Beyond Perfect Competition (Section III.3).........................6 A.3.1 Monopolistic Competition..............................6 A.3.2 Variable Markups...................................7 A.3.3 Endogenous Innovation...............................8 A.3.4 Price Regulations...................................9 A.4 Bilateral Sales (Section VI.1)................................. 12 B Empirical Appendix 12 B.1 Rich versus Poor Countries................................. 12 B.2 Additional Empirical Results................................ 13 B.3 Benchmarking IMS MIDAS data.............................. 13 B.3.1 Benchmarking to the OECD HealthStat Data................... 13 B.3.2 Benchmarking to the MEPS Data.......................... 14 B.4 ATC to GBD Mapping.................................... 15 2 A Theoretical Appendix A.1 Multinational Enterprises (Section III.1) In this appendix, we illustrate how to incorporate multinational production into our basic envi- ronment. Following Ramondo and Rodríguez-Clare(2013), suppose that each firm headquartered in country i that sells drugs targeting disease n in country j 6= i can choose the country l in which its production takes place. If l = i, then the firm exports, if l = j, it engages in horizontal FDI, and if l 6= i, j, it engages in platform FDI. Like in Ramondo and Rodríguez-Clare(2013), we assume that firm-level production functions exhibit constant returns to scale, but we further allow for external economies of scale at the level of the headquarter country for each disease.
    [Show full text]
  • BULGARIA New Development, Trends and In-Depth Information on Selected Issues
    2007 NATIONAL REPORT (2006 data) TO THE EMCDDA by the Reitox National Focal Point BULGARIA New Development, Trends and in-depth information on selected issues REITOX 1 TABLES OF CONTENTS Summary..........................................................................................................................3 Part A: New Trends and Developments 1. National Policies and Context ......................................................................................8 2. Drug use in the General Population and Specific Sub-groups ...................................21 3. Prevention ..................................................................................................................29 4. Problem Drug Use......................................................................................................39 5. Drug-Related Treatment.............................................................................................47 6. Health Correlates and Consequences........................................................................51 7. Responses to Health Correlates and Consequences.................................................65 8. Social correlates and consequences..........................................................................72 9. Response to social correlates and consequences .....................................................82 10. Drug Markets............................................................................................................88 Part B: Selected issues 12. Vulnerable Groups of
    [Show full text]
  • Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL
    EPHMRA ANATOMICAL CLASSIFICATION GUIDELINES 2020 Anatomical Classification Guidelines V2020 "The Anatomical Classification of Pharmaceutical Products has been developed and maintained by the European Pharmaceutical Marketing Research Association (EphMRA) and is therefore the intellectual property of this Association. EphMRA's Classification Committee prepares the guidelines for this classification system and takes care for new entries, changes and improvements in consultation with the product's manufacturer. The contents of the Anatomical Classification of Pharmaceutical Products remain the copyright to EphMRA. Permission for use need not be sought and no fee is required. We would appreciate, however, the acknowledgement of EphMRA Copyright in publications etc. Users of this classification system should keep in mind that Pharmaceutical markets can be segmented according to numerous criteria." © EphMRA 2020 Anatomical Classification Guidelines V2020 CONTENTS PAGE INTRODUCTION A ALIMENTARY TRACT AND METABOLISM 1 B BLOOD AND BLOOD FORMING ORGANS 28 C CARDIOVASCULAR SYSTEM 35 D DERMATOLOGICALS 50 G GENITO-URINARY SYSTEM AND SEX HORMONES 57 H SYSTEMIC HORMONAL PREPARATIONS (EXCLUDING SEX HORMONES) 65 J GENERAL ANTI-INFECTIVES SYSTEMIC 69 K HOSPITAL SOLUTIONS 84 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS 92 M MUSCULO-SKELETAL SYSTEM 102 N NERVOUS SYSTEM 107 P PARASITOLOGY 118 R RESPIRATORY SYSTEM 120 S SENSORY ORGANS 132 T DIAGNOSTIC AGENTS 139 V VARIOUS 141 Anatomical Classification Guidelines V2020 INTRODUCTION The Anatomical Classification was initiated in 1971 by EphMRA. It has been developed jointly by Intellus/PBIRG and EphMRA. It is a subjective method of grouping certain pharmaceutical products and does not represent any particular market, as would be the case with any other classification system.
    [Show full text]
  • Analyses of Spontaneous Adverse Drug Reaction Databases Using Descriptive and Inferential Statistics
    Analyses of Spontaneous Adverse Drug Reaction Databases Using Descriptive and Inferential Statistics Dissertation zur Erlangung des Doktorgrades (PhD) der Medizinischen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn Diana Ivonne Dubrall aus Heidenheim an der Brenz 2020 Angefertigt mit der Genehmigung der Medizinischen Fakultät der Universität Bonn 1. Gutachter: Prof. Dr. rer. nat. Matthias Schmid 2. Gutachter: Prof. Dr. med. Bernhardt Sachs Tag der mündlichen Prüfung: 04.09.2020 Aus dem Institut für Medizinische Biometrie, Informatik und Epidemiologie Direktor: Prof. Dr. rer. nat. Matthias Schmid 3 Table of content Table of content ........................................................................................................ 3 List of abbreviations ................................................................................................. 4 1. Summary ............................................................................................................... 5 2. Introduction ........................................................................................................... 5 3. Objectives ............................................................................................................. 8 4. Methods ................................................................................................................. 8 4.1 BfArM’s ADR database ...................................................................................... 8 4.2 EudraVigilance .................................................................................................
    [Show full text]
  • A Chemoinformatics Approach for the in Silico Identification of Interactions Between Psychiatric Drugs and Plant-Based Food
    Diploma Thesis A Chemoinformatics Approach for the In Silico Identification of Interactions Between Psychiatric Drugs and Plant-Based Food Anna Maria Tsakiroglou Thesis Supervisors: Assoc. Prof.: Kouskoumvekaki Irene Assoc. Prof.: Topakas Evangelos February 2016 Dedication To all the people who made the realization of this work possible. My supervisor for the most useful input and advice along the way. My parents for their unending support. To Katerina, and last, but not least, to Panagiotis, for always being there for me, even from so far away. You are awesome. i ii Abstract The overall objective of this project was the development of a systematic approach for identifying potential interactions between plant-based food and marketed psycholeptics and psychoanaleptic drugs. The problem was addressed, initially, by pairing psychiatric agents and phytochemicals to their common protein targets, using information available in online databases, such as NutriChem 1.0 [21] and Drugbank [16] and constructing the food-drug interaction networks. Thereupon, a search for additional phytochemicals that would be expected to interact with targets of psychiatric drugs was carried out. More specifically, three protein targets, P07550, P28222 and P14416 were selected, based on their frequency of interaction with both psycholeptics and psychoanaleptics and the avail- ability of 3D structural information in PDB [19]. For these protein targets, ligand-based pharmacophoric hypothesis were generated, using experimental activity data from the literature, and the HypoGen feature of Accelrys Discovery Studio (DS) [7]. The phar- macophore models were validated using external test sets and Fisher’s method. Sub- sequently, the models were used as queries to screen the NutriChem 1.0 database for more potentially active phytochemicals.
    [Show full text]
  • Nervous System Drug Poster
    Nervous System Drugs Created by the Njardarson Group (The University of Arizona): Edon Vitaku, Elizabeth A. Ilardi, Daniel J. Mack, Monica A. Fallon, Erik B. Gerlach, Miyant’e Y. Newton, Angela N. Yazzie, Jack Siqueiros, Jón T. Njarðarson Cocaine Aspirin Caffeine Procaine Benzocaine Metharbital Oxycodone Disulfiram Morphine Ergotamine Hydromorphone Codeine Pemoline Amphetamine Thiopental Methadone Methadone Biperiden Thiopental D.H.E. Trimethadione Urecholine Cafergot ( Cocaine ) ( Aspirin ) ( Caffeine ) ( Procaine ) ( Benzocaine ) ( Metharbital ) ( Oxycodone ) ( Disulfiram ) ( Morphine ) ( Ergotamine ) ( Hydromorphone ) ( Codeine ) ( Pemoline ) ( Amphetamine ) ( Thiopental ) ( Methadone ) ( Methadone ) ( Biperiden ) ( Thiopental ) ( Dihydroergotamine ) ( Trimethadione ) ( Bethanechol ) ( Ergotamine & Caffeine ) ANESTHETIC ANALGESIC PSYCHOANALEPTIC ANESTHETIC ANESTHETIC ANTIEPILEPTIC ANALGESIC MISC. NERVOUS ANALGESIC ANALGESIC ANALGESIC ANALGESIC PSYCHOANALEPTIC PSYCHOANALEPTIC ANESTHETIC ANALGESIC MISC. NERVOUS ANTI-PARKINSON PSYCHOLEPTIC ANALGESIC ANTIEPILEPTIC MISC. NERVOUS ANALGESIC Approved 1880 Approved 1899 Approved 1900 Approved 1900 Approved 1902 Approved 1905 Approved 1916 Approved 1920 Approved 1920 Approved 1921 Approved 1926 Approved 1930 Approved 1930 Approved 1933 Approved 1934 Approved 1937 Approved 1937 Approved 1940 Approved 1940 Approved 1946 Approved 1947 Approved 1948 Approved 1948 Lidocaine Artane Anileridine Chlor-Trimeton Clonidine Ethchlorvynol Imipramine Morphine Percodan Paramethadione Secobarbital Apomorphine
    [Show full text]